Market Cap 4.68M
Revenue (ttm) 0.00
Net Income (ttm) -21.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,200
Avg Vol 47,962
Day's Range N/A - N/A
Shares Out 1.32M
Stochastic %K 80%
Beta 1.35
Analysts Hold
Price Target $6.00

Company Profile

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 70 52 10
Website: galecto.com
Address:
Ole Maaloes Vej 3, Copenhagen N, Copenhagen, Denmark
signaljumper
signaljumper Jun. 27 at 1:55 PM
$GLTO looking for break of 4$ in the next 2 weeks
0 · Reply
signaljumper
signaljumper Jun. 26 at 4:01 PM
$GLTO time will buyout on this stock
0 · Reply
US_Bull
US_Bull Jun. 23 at 11:04 AM
$GLTO Options given 3 days ago with exercise price of 3.22$ they must feel pretty confident that SP will keep rising or else they would have issued those options at a lower exercise price. https://galecto.gcs-web.com/static-files/0fcbc34a-8b86-481c-a71d-5ef8ebf6d25c
0 · Reply
Kilarck
Kilarck Jun. 22 at 5:19 PM
$GLTO https://talkmarkets.com/content/stocks--equities/galectin-therapeutics-is-undervalued-and-with-short-squeeze-underway?post=504960 Short squeeze on another Galectin inhibitor underway!!!
0 · Reply
US_Bull
US_Bull Jun. 20 at 7:54 PM
$GLTO Slowly but surely rising I prefer it that way when it is under the radar of retail until they dropped the PR to start the rocket launch.
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 20 at 7:24 PM
$GLTO giddyup dammit! 😂
0 · Reply
joe77w
joe77w Jun. 20 at 1:25 PM
$GLTO 13 mln in net equity and 1.3 mln os does mean 10 usd per share, two promising compounds, significantly cheap and undervalued https://www.otcmarkets.com/filing/html?id=18446825&guid=G4i-k67MdXvnJth
0 · Reply
US_Bull
US_Bull Jun. 20 at 12:01 PM
$GLTO Here we go!!!
0 · Reply
US_Bull
US_Bull Jun. 20 at 11:09 AM
$GLTO Loaded more pre-market.
0 · Reply
US_Bull
US_Bull Jun. 20 at 1:36 AM
$GLTO I agree any day now this one rockets straight up part of the downpour has also been weak bio sector selloff for past few months. Microfloat can make this rocket out of the blue sympathy play let alone any hint of positive pr. I see double digits in few weeks.
0 · Reply
Latest News on GLTO
Galecto Reports Full-Year 2024 Financial Results

Mar 19, 2025, 4:45 PM EDT - 3 months ago

Galecto Reports Full-Year 2024 Financial Results


Galecto to Participate in Upcoming Investor Conferences

Feb 6, 2025, 8:00 AM EST - 5 months ago

Galecto to Participate in Upcoming Investor Conferences


Galecto Reports Third Quarter 2024 Financial Results

Nov 1, 2024, 8:30 AM EDT - 8 months ago

Galecto Reports Third Quarter 2024 Financial Results


Galecto Announces Reverse Stock Split

Aug 28, 2024, 9:00 AM EDT - 11 months ago

Galecto Announces Reverse Stock Split


Galecto Announces Plans to Explore Strategic Alternatives

Sep 26, 2023, 4:01 PM EDT - 1 year ago

Galecto Announces Plans to Explore Strategic Alternatives


Galecto to Present at Investor Conferences in September

Aug 31, 2023, 11:00 AM EDT - 2 years ago

Galecto to Present at Investor Conferences in September


Galecto to discontinue development of lung disease treatment

Aug 15, 2023, 7:55 AM EDT - 2 years ago

Galecto to discontinue development of lung disease treatment


Galecto Reports Second Quarter Operating and Financial Results

Jul 31, 2023, 4:05 PM EDT - 2 years ago

Galecto Reports Second Quarter Operating and Financial Results


Galecto Set to Join Russell Microcap® Index

Jun 20, 2023, 8:58 AM EDT - 2 years ago

Galecto Set to Join Russell Microcap® Index


Galecto Reports First Quarter Operating and Financial Results

Apr 28, 2023, 8:00 AM EDT - 2 years ago

Galecto Reports First Quarter Operating and Financial Results


Galecto: Promising Pipeline And Excellent Risk-Reward

Apr 18, 2023, 7:01 PM EDT - 2 years ago

Galecto: Promising Pipeline And Excellent Risk-Reward


Galecto to Present Two Posters at AACR Annual Meeting 2023

Apr 13, 2023, 8:30 AM EDT - 2 years ago

Galecto to Present Two Posters at AACR Annual Meeting 2023


Galecto Reports Third Quarter Operating and Financial Results

Nov 8, 2022, 9:15 AM EST - 2 years ago

Galecto Reports Third Quarter Operating and Financial Results


Galecto to Participate at Jefferies Healthcare Conference

May 31, 2022, 8:30 AM EDT - 3 years ago

Galecto to Participate at Jefferies Healthcare Conference


Galecto to Present at Upcoming Investor Conferences

Oct 26, 2021, 8:00 AM EDT - 4 years ago

Galecto to Present at Upcoming Investor Conferences


signaljumper
signaljumper Jun. 27 at 1:55 PM
$GLTO looking for break of 4$ in the next 2 weeks
0 · Reply
signaljumper
signaljumper Jun. 26 at 4:01 PM
$GLTO time will buyout on this stock
0 · Reply
US_Bull
US_Bull Jun. 23 at 11:04 AM
$GLTO Options given 3 days ago with exercise price of 3.22$ they must feel pretty confident that SP will keep rising or else they would have issued those options at a lower exercise price. https://galecto.gcs-web.com/static-files/0fcbc34a-8b86-481c-a71d-5ef8ebf6d25c
0 · Reply
Kilarck
Kilarck Jun. 22 at 5:19 PM
$GLTO https://talkmarkets.com/content/stocks--equities/galectin-therapeutics-is-undervalued-and-with-short-squeeze-underway?post=504960 Short squeeze on another Galectin inhibitor underway!!!
0 · Reply
US_Bull
US_Bull Jun. 20 at 7:54 PM
$GLTO Slowly but surely rising I prefer it that way when it is under the radar of retail until they dropped the PR to start the rocket launch.
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 20 at 7:24 PM
$GLTO giddyup dammit! 😂
0 · Reply
joe77w
joe77w Jun. 20 at 1:25 PM
$GLTO 13 mln in net equity and 1.3 mln os does mean 10 usd per share, two promising compounds, significantly cheap and undervalued https://www.otcmarkets.com/filing/html?id=18446825&guid=G4i-k67MdXvnJth
0 · Reply
US_Bull
US_Bull Jun. 20 at 12:01 PM
$GLTO Here we go!!!
0 · Reply
US_Bull
US_Bull Jun. 20 at 11:09 AM
$GLTO Loaded more pre-market.
0 · Reply
US_Bull
US_Bull Jun. 20 at 1:36 AM
$GLTO I agree any day now this one rockets straight up part of the downpour has also been weak bio sector selloff for past few months. Microfloat can make this rocket out of the blue sympathy play let alone any hint of positive pr. I see double digits in few weeks.
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 19 at 10:26 PM
$GLTO all the excitement over GALT is about to trigger an avalanche over here! After listening to GALTs KOL I think belapectin is approvable. FOMO traders will be looking for other galectin biology plays and GLTO is it. Selvigaltin is further away in liver disease but closer for cancer. Traders will go nuts when they realize GLTO float is only 1M shares and MC just $4M. The fact that selvigaltin is also oral makes this even more appealing. GALT is developing an oral version of belapectin but is still pre clinical and will have to run additional trials including P3 for the oral version. It’s about to get exciting over here and it’s about time!
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 19 at 6:03 PM
$GLTO 👀 good news for $GALT is going to spill over to GLTO. GALT leads in liver disease while GLTO leads in cancer. My sense is Merck is lurking since they’re supplying Keytruda for the IIT P2 trial in MM & HNSCS. Early look coming any time. I believe Galecto plans to offload Selvigaltin (GB1211) to Merck with large payment and CVRs to progress GB3226 in AML. That’s why Galecto didn’t do a PIPE at favorable pricing with their SA and why they’ve essentially been dark. More good news and for GALT will put more eyes on GLTO. With only 1M share float it won’t take much to send this 😉
3 · Reply
US_Bull
US_Bull Jun. 19 at 2:46 PM
$GLTO Low float dangerous cocktail for shorts any news they PR this is flying hard getting the tail wind from a pathetically low market cap compared to other Gal-3 inh plays, the fact that it is ultra low-float, and the Danish parlament cutting the phantom tax.
1 · Reply
US_Bull
US_Bull Jun. 19 at 1:59 PM
$GLTO Just recently the 'phantom tax' in Denmark has been abolished that should further boost the company significantly just makes this company a greater buy now. "When passed, the new law will allow founders to defer taxes on proceeds from company sales that depend on future milestone payments — only paying tax if and when those payments actually arrive." Probably why the chart has turned bullish North again.
1 · Reply
US_Bull
US_Bull Jun. 19 at 10:04 AM
$GLTO Finally chart looks extremely bullish could get a sympathy push from GALT run since they both basically target Gal-3 and are polysaccharide molecules.
0 · Reply
US_Bull
US_Bull Jun. 19 at 10:03 AM
$GLTO Lol they have a market cap of about 4.4 million and they have 11 million in the bank with no debt 4 drugs in the pipeline for cancer and NASH cirrh. what am I missing here lol. Next huge gem runner. And they are supported by Novo Nordic seed.
0 · Reply
kshonstocks
kshonstocks Jun. 18 at 10:05 PM
$GLTO nice pattern developing
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 18 at 6:59 PM
$GLTO $GALT market cap crosses $200M 😯
0 · Reply
US_Bull
US_Bull Jun. 18 at 3:24 PM
$GLTO MArket cap is way too low here.
0 · Reply
US_Bull
US_Bull Jun. 18 at 3:24 PM
$GLTO GALT running sympathy play here in with 6375 shares.
0 · Reply
sixmilliondollarman
sixmilliondollarman Jun. 18 at 1:45 PM
$GLTO GALT marker cap up to ~$160M. Renewed interest in galectin-3
0 · Reply
globaldaytraderzzzzzzz
globaldaytraderzzzzzzz Jun. 12 at 1:02 PM
$GLTO # wo to ldwide slap nowww
0 · Reply